Critical Determinants of Cardiovascular Risk in Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|1|21-26

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.1, 2011-01, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

By Nurmohamed M.T.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1599-1609

Adis International

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J   Allanore Y  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1502-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-01 ,pp. : 81-93

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular disease – the silent killer in rheumatoid arthritis

By Kumar Namita   Armstrong David J  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 384-387

Royal College Of Physicians

Access to resources Recommend Favorite